PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2024 Earnings Call Transcript November 14, 2024
Operator: Good morning ladies and gentlemen and welcome to PDS Biotech’s Third Quarter 2024 Results and Clinical Strategy Update Conference Call. All participants are currently in listen-only mode. Following the formal presentation, we’ll open up the call for question-and-answer session. I would now like to turn the conference over to Tom Johnson of LifeSci Advisors. Please go ahead, sir.
Tom...
